| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.65 | $164,850.00 | - | -20.5% | -31.9% | |
| Apr 1, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,000 | $140.48 | $421,428.19 | -0.7% | +20.1% | +44.5% | |
| Apr 1, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 25,461 | $139.70 | $3,556,947.64 | -2.0% | +20.1% | +44.5% | |
| Mar 31, 2025 | A Agilent Technologies, Inc. | Podolsky Daniel K | Director | Sell | 1,819 | $116.46 | $211,844.38 | -4.8% | +0.9% | -2.6% | |
| Mar 31, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,562 | $138.41 | $354,603.27 | -1.7% | +19.5% | +41.4% | |
| Mar 31, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 1,404 | $138.41 | $194,326.94 | -0.3% | +19.5% | +41.4% | |
| Mar 28, 2025 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 150,000 | $1.70 | $254,385.00 | - | -22.4% | -34.1% | |
| Mar 26, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,644 | $20.30 | $114,573.20 | -2.5% | -4.6% | +23.0% | |
| Mar 26, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 46,551 | $95.62 | $4,451,084.37 | -32.1% | -5.7% | -36.4% | |
| Mar 26, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 8,746 | $95.61 | $836,210.93 | -21.3% | -5.7% | -36.4% | |
| Mar 25, 2025 | XGN Exagen Inc. | Nmsic Co-Investment Fund, L.P. | 10% Owner | Sell | 350,000 | $3.30 | $1,155,000.00 | -16.6% | +80.6% | -25.4% | |
| Mar 20, 2025 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 230 | $41.68 | $9,585.48 | -0.2% | -14.6% | +0.0% | |
| Mar 20, 2025 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 1,726 | $41.68 | $71,932.78 | -0.3% | -14.6% | +0.0% | |
| Mar 20, 2025 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 291 | $41.68 | $12,127.72 | -0.2% | -14.6% | +0.0% | |
| Mar 19, 2025 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 116 | $43.70 | $5,069.20 | -3.5% | +7.1% | +92.6% | |
| Mar 19, 2025 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 15,000 | $49.42 | $741,300.00 | -1.4% | +11.5% | +23.5% | |
| Mar 18, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,881 | $145.62 | $856,410.26 | -0.5% | +15.0% | +35.2% | |
| Mar 17, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 1,127 | $146.04 | $164,583.86 | - | +12.7% | +32.9% | |
| Mar 17, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 1,026 | $146.04 | $149,835.56 | -0.4% | +12.7% | +32.9% | |
| Mar 17, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 928 | $146.04 | $135,521.13 | -0.2% | +12.7% | +32.9% | |
| Mar 17, 2025 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 1,908 | $121.98 | $232,691.32 | -8.1% | -2.8% | -8.0% | |
| Mar 17, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 792 | $146.04 | $115,661.03 | -0.5% | +12.7% | +32.9% | |
| Mar 17, 2025 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 200,000 | $1.74 | $347,820.00 | - | -26.5% | -34.3% | |
| Mar 17, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 795 | $146.04 | $116,099.12 | -0.3% | +12.7% | +32.9% | |
| Mar 17, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 6,702 | $146.03 | $978,677.65 | -3.2% | +12.7% | +32.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.